Sermorelin

Also known as: Geref

Status

No approved product. The original product (Geref) was FDA-approved for diagnosing growth hormone deficiency and later discontinued in the US. No approved product exists today; what circulates is compounded or research-grade.

What it is

A short GHRH analogue — the first 29 amino acids of the 44-amino-acid hormone. It asks the pituitary to release growth hormone in a pulse, which is how the body does it naturally, rather than supplying growth hormone directly.

Source

Former FDA prescribing information (Geref); no current approved product

Sources

No linked primary source is on file for this entry yet.

Educational use only, never medical advice. No doses.